They help in early detection of infertility and assist couples in effectively planning their pregnancies. The global fertility test market has witnessed considerable traction over the years, owing to the rising prevalence of infertility as a result of changing lifestyles. Additionally, delayed pregnancies among women and rising awareness about fertility health have further propelled the demand for self-monitoring ovulation tests and other predictive fertility products. The global fertility test market is estimated to be valued at US$ 579.1 Mn in 2023 and is expected to exhibit a CAGR of 4.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The fertility test market growth isexpected to be predominantly driven by increasing adoption in developing economies over the forecast period. Traditionally, self-monitoring ovulation tests were largely confined to developed regions owing to higher awareness levels. However, the availability of low-cost fertility test kits is gradually increasing their adoption in developing Asian and Latin American countries where individuals have become more aware about fertility health. Furthermore, the rapid urbanization and rising disposable incomes have made fertility tests more accessible to consumers in the developing world. This is expected to significantly boost the overall market expansion during the forecast period.
Segment Analysis
The Global fertility test market size is segmented into product, sample type, mode of purchase, application, and end-use. The fertility monitors segment dominates the market due to growing preference for non-invasive and easy to use fertility monitoring devices in order to plan and track fertility cycle. The devices in this segment help calculate fertile days indicating ovulation and assist couples in effective family planning.
Key Takeaways
The global fertility test market is expected to witness high growth over the forecast period. The increasing concerns regarding fertility due to rising cases of infertility and delayed pregnancy are major factors driving market growth.
Regional analysis: North America accounts for the largest share in the global fertility test market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of key players, rising infertility rates, increased awareness about fertility tests, and access to advanced healthcare facilities in the region.
Key players operating in the fertility test market are AstraZeneca, Novartis AG, GSP plc, Merck & Co., Inc., Verona Pharma plc, Regeneron Pharmaceuticals Inc., Boehringer Ingelheim International GmbH.
Get More Insights On This Topic: https://www.newsstatix.com/fertility-tests-market-size-share-analysis-2023-2030/
Explore More Trending Article On This Topic: https://filmik.in/cracking-the-code-of-epigenetics-the-harmony-of-gene-expression-outside-of-dna/
Comments
0 comment